Congratulations to the 11 current researchers with principal investigator (PI) status at UHN who have made the coveted 2023 list of Highly Cited Researchers from Clarivate—a global leader in bibliometrics and analytics. A total of 7,125 Highly Cited Researcher designations were awarded to 6,849 individuals from 67 countries.
Citations, the acknowledgment of a scientific article in subsequent research, serve as a concrete metric of a publication's influence within a specific field. The Clarivate Highly Cited Researcher accolade is a testament to those whose publications over the past decade rank among the top 1% most-cited publications in their respective fields and publication years.
Notably, 7 of UHN's PIs on the list received the added distinction of being included in the ‘Cross-Field’ category, underscoring their interdisciplinary excellence and impact in multiple research fields.
Dr. Brad Wouters, Executive Vice-President of Science and Research at UHN, expresses admiration for these PIs, “These are exceptional leaders in their fields. Their work is not only making waves in the global scientific community but also driving the development of clinical innovations, making our vision of A Healthier World a reality. We take pride in their accomplishments and are honoured to celebrate their achievements.”
The UHN PIs and the categories in which they received their distinction are listed below. To read more, see the Clarivate press release.
Dr. Cheryl Arrowsmith | Cross-Field
Senior Scientist, Princess Margaret Cancer Centre
Research focus: Cancer-related structural biology, chemical biology and epigenetics.
Dr. Gary Bader | Cross-Field
Affiliate Scientist, Princess Margaret Cancer Centre
Research focus: Bridging molecular and clinical datasets to identify clinically relevant targets of cancer and regenerative wound healing processes.
Dr. Slava Epelman | Immunology
Senior Scientist, Toronto General Hospital Research Institute
Research focus: The contribution of immune cells to cardiac tissue injury and repair.
Dr. Eddy Fan | Clinical Medicine
Scientist, Toronto General Hospital Research Institute
Research focus: Advanced life support for acute respiratory failure and patient outcomes from critical illness.
Dr. Michael Fehlings | Cross-Field
Senior Scientist, Krembil Research Institute
Research focus: Studying spinal cord injuries by combining different scientific methods to understand and treat damage.
Dr. Steven Gallinger | Cross-Field
Clinician Scientist, Princess Margaret Cancer Centre
Research focus: Cancer genetics, including gastrointestinal, colorectal and pancreatic cancers.
Dr. Anthony Lang | Neuroscience and Behavior
Senior Scientist, Krembil Research Institute
Research focus: The disease etiology, pathogenesis and treatment of Parkinson disease and related movement disorders.
Dr. Andres Lozano | Cross-Field
Senior Scientist, Krembil Research Institute
Research focus: Brain mapping, deep brain stimulation and focused ultrasound in patients and experimental models of brain diseases
Dr. Tak Mak | Cross-Field
Senior Scientist, Princess Margaret Cancer Centre
Research focus: The mechanisms underlying immune responses and the pathogenesis and tumorigenesis of cancer.
Dr. Roger McIntyre | Psychiatry and Psychology
Clinician Investigator, Krembil Research Institute
Research focus: The effects of mood disorders on cognitive function, related health conditions and workplace functioning.
Dr. Lillian Siu | Cross-Field
Senior Scientist, Princess Margaret Cancer Centre
Research focus: New anticancer drug development, particularly with respect to head and neck malignancies.